Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein–protein interaction through structure-based drug design
Keywords: طراحی دارو مبتنی بر ساختار; HDM2; p53; Protein–protein interaction; HDM2 antagonist; Pharmacokinetic; Structure-based drug design